Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Diabetes Research
|
February 19, 2026
Exploring the Use of Hybrid Closed-Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot
Jennifer Hagan, Tomás P Griffin, Radhika Chauhan, et al.
Diabetes, Obesity & Metabolism
|
March 24, 2022
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists
Thomas S J Crabtree, Karen Adamson, Hazel Reid, et al.
Diabetes, Obesity & Metabolism
|
April 24, 2026
Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis-Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia
Alexandros L Liarakos, Ashveer Randhay, Lalantha Leelarathna, et al.
Diabetes, Obesity & Metabolism
|
June 8, 2026
Associations Between Patient-Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin-Treated Diabetes Receiving Haemodialysis
Alexandros L Liarakos, Ashveer Randhay, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics
|
January 27, 2025
Long-Term Improvements in Glycemia and User-Reported Outcomes Associated with Open-Source Automated Insulin Delivery Systems in Adults with Type 1 Diabetes in the United Kingdom: A Real-World Observational Study
Alexandros L Liarakos, Thomas S J Crabtree, Sufyan Hussain, et al.
Diabetes Research and Clinical Practice
|
February 28, 2024
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study
Alexandros L Liarakos, Nebras Hasan, Thomas S J Crabtree, et al.
Diabetes Care
|
August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
Thomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
The Lancet. Diabetes & Endocrinology
|
February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial
Emma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
The Lancet. Diabetes & Endocrinology
|
April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
Emma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Diabetes Technology & Therapeutics
|
May 30, 2025
Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study
Alexandros L Liarakos, Thomas S J Crabtree, Tomás P Griffin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Diabetes Research
|
February 19, 2026
Exploring the Use of Hybrid Closed-Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot
Jennifer Hagan, Tomás P Griffin, Radhika Chauhan, et al.
Diabetes, Obesity & Metabolism
|
March 24, 2022
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists
Thomas S J Crabtree, Karen Adamson, Hazel Reid, et al.
Diabetes, Obesity & Metabolism
|
April 24, 2026
Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis-Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia
Alexandros L Liarakos, Ashveer Randhay, Lalantha Leelarathna, et al.
Diabetes, Obesity & Metabolism
|
June 8, 2026
Associations Between Patient-Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin-Treated Diabetes Receiving Haemodialysis
Alexandros L Liarakos, Ashveer Randhay, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics
|
January 27, 2025
Long-Term Improvements in Glycemia and User-Reported Outcomes Associated with Open-Source Automated Insulin Delivery Systems in Adults with Type 1 Diabetes in the United Kingdom: A Real-World Observational Study
Alexandros L Liarakos, Thomas S J Crabtree, Sufyan Hussain, et al.
Diabetes Research and Clinical Practice
|
February 28, 2024
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study
Alexandros L Liarakos, Nebras Hasan, Thomas S J Crabtree, et al.
Diabetes Care
|
August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
Thomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
The Lancet. Diabetes & Endocrinology
|
February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial
Emma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
The Lancet. Diabetes & Endocrinology
|
April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial
Emma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Diabetes Technology & Therapeutics
|
May 30, 2025
Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study
Alexandros L Liarakos, Thomas S J Crabtree, Tomás P Griffin, et al.
Page
of 2